Lansforsakringar Fondforvaltning AB (publ)
Position in ILMN — Illumina, Inc.
CIK 2059323
Stockholm, V7
Position in ILMN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$7,881,931
+$1,894,947 QoQ
Shares Held
44,827
-7.7% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#206
of 932 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ILMN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Lansforsakringar Fondforvaltning AB (publ) holds $191,892,065 across 12 Diagnostics & Research names. ILMN ranks #9 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
131,916 | $66,137,405 | |
| 2 | DHR |
Danaher Corp /De/
|
196,388 | $37,407,986 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
24,161 | $12,719,316 | |
| 4 | A |
Agilent Technologies, Inc.
|
88,456 | $11,749,610 | |
| 5 | WAT |
Waters Corp /De/
|
30,952 | $11,608,238 | |
| 6 | NTRA |
Natera, Inc.
|
40,580 | $11,015,441 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
51,226 | $9,897,887 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
6,414 | $8,193,949 |
All Filings in ILMN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,881,931 | 44,827 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $5,986,984 | 48,572 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $6,512,487 | 49,653 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $4,700,445 | 49,494 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $4,932,315 | 51,696 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $4,214,144 | 53,115 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $7,144,260 | 53,463 | Shares | Sole | 2025-04-14 | |
| No filing history on record for this holder in this stock. | ||||||